Company / Inventory
Boston Scientific Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$2.9B
FY2025
5-year range
$1.6B / $2.9B
FY2021-FY2025
Trend
+4.7%
vs FY2024
Sector context
#12 of 115
Health Care
What the data says
Among 115 Health Care companies, Boston Scientific is in the top 10% for inventory. Inventory has increased for 5 consecutive years, from $1.4B in FY2020 to $2.9B in FY2025.
Based on SEC 10-K filings.
$2.9B in FY2025 with a 5-year CAGR of +16.8%. Top quartile in the Health Care sector.
Improved from $2.5B to $2.9B over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +16.4%
- 5-Year CAGR
- +16.8%
- 10-Year CAGR
- -
Sector benchmark
Top 10% in Health CareTop 10% of 115This company $2.9B Sector average $1.4B
▼
+109.6% above sector average
Key checks
Key Insights
- Boston Scientific's inventory has grown for 5 consecutive years.
- 5-year CAGR of +16.8%, indicating consistent growth.
- In FY2025, inventory increased 4.7% year-over-year.
- Ranks #12 out of 115 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.9B | +4.7% |
| FY2024 | $2.8B | +13.1% |
| FY2023 | $2.5B | +33.0% |
| FY2022 | $1.9B | +16.0% |
| FY2021 | $1.6B | +19.2% |
| FY2020 | $1.4B | -14.4% |
| FY2019 | $1.6B | +35.4% |
| FY2018 | $1.2B | +8.2% |
| FY2017 | $1.1B | +12.9% |
| FY2016 | $955.0M | -6.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026